Abstract
Genetic Engineering & Biotechnology NewsVol. 42, No. 5 Infectious DiseaseProven mRNA Technologies Embolden Vaccine and Drug MakersThe two RNA-based COVID-19 vaccines merely hint at future advances, which range from novel therapeutics to distributed production systemsVivienne Raper, PhDVivienne Raper, PhDSearch for more papers by this authorPublished Online:10 May 2022https://doi.org/10.1089/gen.42.05.08AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 42Issue 5May 2022 Information© 2022 by GEN PublishingTo cite this article:Vivienne Raper, PhD.Proven mRNA Technologies Embolden Vaccine and Drug Makers.Genetic Engineering & Biotechnology News.May 2022.22-24, 26.http://doi.org/10.1089/gen.42.05.08Published in Volume: 42 Issue 5: May 10, 2022PDF download
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call